January 11, 2019 by B. Douglas Hoey
B. Douglas Hoey, National Community Pharmacists Association, Simplifying the pharmacy payment model
Featured Articles, Leading Headlines, Pharmacy
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. One thing that can be said about the state of prescription medications in 2019 is that the pharmacy payment model is complex, convoluted and confusing. Over $400 billion dollars are spent on prescription drugs, yet finding someone in the distribution
October 10, 2018 by Chain Drug Review
and S. 2554, B. Douglas Hoey, National Community Pharmacists Association, S. 2553, the Know the Lowest Price Act of 2018, the Patient Right to Know Drug Prices Act
Leading Headlines, Pharmacy
WASHINGTON— Four National Community Pharmacists Association leaders joined President Trump at the White House today as he signed legislation prohibiting so-called pharmacy “gag clauses” that may result in patients being charged inflated prices for their medications. Attending were newly-installed president Bill Osborn, owner of Osborn Drugs in Miami, Okla.; NCPA board members Michele M. Belcher, owner of Grants
October 9, 2018 by Chain Drug Review
Bill Osborn, National Community Pharmacists Association, NCPA’s House of Delegates
Leading Headlines, Pharmacy
BOSTON – Pharmacist Bill Osborn, of Osborn Drugs, Inc. in Miami, Okla., was installed as 2018-2019 president of the National Community Pharmacists Association at the organization’s recent annual convention in Boston. “Our profession has had many challenges in the past and we have persevered,” Osborn said in remarks to NCPA’s House of Delegates. “We can continue to
October 8, 2018 by Chain Drug Review
David Smith, Jim Spoon, National Community Pharmacists Association, Rusty Field, Upsher-Smith, Willard B. Simmons Independent Pharmacist of the Yea
Leading Headlines, Pharmacy
BOSTON – Jim Spoon, owner of Spoon Drug in Sand Springs, Okla., has been named the National Community Pharmacists Association 2018 Willard B. Simmons Independent Pharmacist of the Year. The award is sponsored by Upsher-Smith Laboratories. Spoon received the award at NCPA’s recent 2018 Annual Convention in Boston. The Independent Pharmacist of the Year award recognizes an independent pharmacist
October 8, 2018 by Chain Drug Review
Calvin J. Anthony Lifetime Achievement Award, David Smith, Laird Miller, National Community Pharmacists Association, NCPA 2018 Lifetime Achievement Award
Pharmacy
BOSTON – Laird Miller of Gainesville, Ga., received the 2018 Calvin J. Anthony Lifetime Achievement Award from the National Community Pharmacists Association at NCPA’s recent annual convention here.. “Laird Miller has long been devoted to independent community pharmacy and its patients, including through his efforts to promote community-based prescription drug abuse prevention and his long service on
October 3, 2018 by Chain Drug Review
National Community Pharmacists Association, Tax Cuts and Jobs Act, Treasury Secretary Steven Mnuchin
Leading Headlines
ALEXANDRIA, Va. –The National Community Pharmacists Association, which represents the owners of 22,000 small businesses, is seeking clarification on community pharmacists’ ability to obtain the pass-through deduction under the Tax Cuts and Jobs Act. The association provided comments this week to Treasury Secretary Steven Mnuchin on the Qualified Business Income Deduction proposed rule. NCPA has long advocated for
September 5, 2018 by Chain Drug Review
gag clauses, Hugh Chancy, National Community Pharmacists Association, Subcommittee on Health hearing
Leading Headlines, Pharmacy, Retail News
ALEXANDRIA, Va. — In testimony before the U.S. House Energy and Commerce Subcommittee on Health today, pharmacist-owner Hugh Chancy urged support for draft legislation to prohibit restrictive contractual language, often referred to as “gag clauses,” that may result in patients being charged inflated prices for their medications. Chancy, who owns Chancy Drugs in Hahira, Ga., testified on behalf of the
August 23, 2018 by Chain Drug Review
B. Douglas Hoey, National Community Pharmacists Association, nne Cassity
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — National Community Pharmacists Association’s chief executive officer Douglas Hoey announced that Anne Cassity has joined NCPA as vice president, federal and state government affairs, as the organization continues to grow its advocacy influence. A seasoned government affairs professional, Cassity formerly managed NCPA’s federal advocacy program. She left NCPA in 2011 to become health care
August 23, 2018 by B. Douglas Hoey
Doug Hoey, National Community Pharmacists Association, pharmacy benefit managers
Issue 08-13-2018, Opinion
NEW YORK — Physicians Robin Warren and Barry Marshall were practically laughed out of health care in 1982 when they suggested that a type of bacteria might be causing stomach ulcers. It took more than a decade before their theory that treating ulcers with antibiotics to kill H. pylori bacteria was validated, and it radically
July 13, 2018 by Chain Drug Review
B. Douglas Hoey, Medicare Part D, Morning Consult, National Community Pharmacists Association
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — Reducing drug costs borne by seniors due to middlemen and deals in the drug supply chain are Medicare Part D reforms that most strongly curry favor among registered voters, according to a Morning Consult survey commissioned by the National Community Pharmacists Association (NCPA). Conducted in late June, the survey results indicate strong support
June 11, 2018 by Chain Drug Review
Department of Defense, NACDS, National Community Pharmacists Association, Tricare
Featured Articles, Leading Headlines, Pharmacy
WASHINGTON — In the first step in the stakeholder process recommended by lawmakers in a letter to the Department of Defense (DoD) in April, the National Association of Chain Drug Stores (NACDS), the National Community Pharmacists Association and the Pharmaceutical Research and Manufacturers of America (PhRMA) have been invited to participate in a DoD-hosted meeting
March 16, 2018 by Chain Drug Review
American Pharmacists Association, B. Douglas Hoey, Claire McCaskill, CVS Health, Debbie Stabenow, Know the Lowest Price Act, National Community Pharmacists Association, Patient Right to Know Drug Prices Act, Pharmaceutical Care Management Association, pharmacy gag clauses, prescription drug pricing transparency, S. 2553, S. 2554, Susan Collins, Tom Menighan
Featured Articles, Leading Headlines, Pharmacy, Retail News
WASHINGTON — A group of senators are sponsoring legislation to bring more prescription drug pricing transparency to the pharmacy counter. Sens. Susan Collins (R., Maine), Claire McCaskill (D., Mo.) and Debbie Stabenow (D., Mich.) yesterday introduced the Patient Right to Know Drug Prices Act (S. 2554) and the Know the Lowest Price Act (S. 2553), which would
February 12, 2018 by Geoff Walden and Chain Drug Review
B. Douglas Hoey, Centers for Medicare & Medicaid Services, DIR fees, direct and indirect remuneration fees, NACDS, National Association of Chain Drug Stores, National Community Pharmacists Association, NCPA, PCMA, Pharmaceutical Care Management Association, Steve Anderson
2018, Issue 02-12-2018, Issues, News
ARLINGTON, Va. — The “untenable” procedures around direct and indirect remuneration fees (DIR fees) can be righted with measures reducing costs for beneficiaries and the government, while promoting a more quality-driven health care system, says the National Association of Chain Drug Stores. NACDS expressed that message in comments to the Centers for Medicare & Medicaid
February 9, 2018 by CDR Blog and Chain Drug Review
B. Douglas Hoey, Centers for Medicare & Medicaid Services, DIR fees, direct and indirect remuneration fees, independent pharmacy owners, Medicare Part D, National Community Pharmacists Association, NCPA, S. 413 / H.R. 1038
CDR Blog
Suffice it to say, community pharmacies are getting squeezed by retroactive DIR fees. That’s what the results of a survey from the National Community Pharmacists Association said. NCPA reported Friday that, because of retroactive direct and indirect remuneration fees, 84% of independent pharmacy owners polled said they don’t know what their final reimbursement will be at